Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
The European Journal of Health Economics
Erschienen in: The European Journal of Health Economics 4/2017

05.05.2016 | Original Paper

A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events

verfasst von: Anne-Line Couillerot-Peyrondet, Cléa Sambuc, Yoël Sainsaulieu, Cécile Couchoud, Isabelle Bongiovanni-Delarozière

Erschienen in: The European Journal of Health Economics | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Objectives

In the current pressured economic context, and to continue to treat the growing number of patients with high-quality standards, the first step is to have a better understanding of the costs related to end-stage renal disease (ESRD) treatment according to various renal replacement therapy, age, diabetes status, and clinical events.

Methods

In order to estimate the direct costs of all adult ESRD patients, according to (RRT) modality, patient condition, and clinical events, data from the French national health insurance funds were used.

Results

The mean monthly costs for the 47,862 stable prevalent patients (73 % of the population) varied substantially according to treatment modality (from 7300€ for in-center hemodialysis to 1100€ for a functioning renal graft) and to clinical event (8300€ for the first month of dialysis, 11,000€ for the last month before death, 22,800€ for the first month after renal transplantation). Mean monthly costs varied according to diabetic status and to age to a lesser extent.

Conclusions

These results demonstrate, for the first time in France and in Europe, the importance of a dynamic view of renal care and the bias likely when comparing treatments in cross-sectional studies.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Ashton, T., Marshall, M.R.: The organization and financing of dialysis and kidney transplantation services in New Zealand. Int. J. Health Care Financ. Econ. 7(4), 233–252 (2007)CrossRef
2.
Manns, B.J., Mendelssohn, D.C., Taub, K.J.: The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care. Int. J. Health Care Financ. Econ. 7(2–3), 149–169 (2007)CrossRef
3.
USRDS. US Renal Data System, USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States (2012)
4.
Kerr, M., Bray, B., Medcalf, J., O’Donoghue, D.J., Matthews, B.: Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol. Dial. Transplant. Suppl 3, iii73–iii80 (2012)
5.
Dor, A., Pauly, M.V., Eichleay, M.A., Held, P.J.: End-stage renal disease and economic incentives: the international study of health care organization and financing (ISHCOF). Int. J. Health Care Financ. Econ. 7(2–3), 73–111 (2007)CrossRef
6.
Hirth, R.A.: The organization and financing of kidney dialysis and transplant care in the United States of America. Int. J. Health Care Financ. Econ. 7(4), 301–318 (2007)CrossRef
7.
Kaitelidou, D., Ziroyanis, P.N., Maniadakis, N., Liaropoulos, L.L.: Economic evaluation of hemodialysis: implications for technology assessment in Greece. Int. J. Technol. Assess. Health Care 21(1), 40–46 (2005)CrossRefPubMed
8.
Pontoriero, G., Pozzoni, P., Vecchio, L.D., Locatelli, F.: International study of health care organization and financing for renal replacement therapy in Italy: an evolving reality. Int. J. Health Care Financ. Econ. 7(2–3), 201–215 (2007)CrossRef
9.
Luno, J.: The organization and financing of end-stage renal disease in Spain. Int. J. Health Care Financ. Econ. 7(4), 253–267 (2007)CrossRef
10.
Van Biesen, W., Lameire, N., Peeters, P., Vanholder, R.: Belgium’s mixed private/public health care system and its impact on the cost of end-stage renal disease. Int. J. Health Care Financ. Econ. 7(2–3), 133–148 (2007)CrossRef
11.
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 385(9963), 117–171 (2015)
12.
Ricci, P., Blotiere, P.O., Weill, A.: Diabète traité: quelles évolutions entre 2000 et 2009 en France? Bull Epidémiol Hebd 42–43, 434–440 (2010)
13.
Icks, A., Haastert, B., Gandjour, A., Chernyak, N., Rathmann, W., Giani, G., et al.: Costs of dialysis—a regional population-based analysis. Nephrol. Dial. Transplant. 25(5), 1647–1652 (2010)CrossRefPubMed
14.
Baboolal, K., McEwan, P., Sondhi, S., Spiewanowski, P., Wechowski, J., Wilson, K.: The cost of renal dialysis in a UK setting—a multicentre study. Nephrol. Dial. Transplant. 23(6), 1982–1989 (2008)CrossRefPubMed
15.
Benain, J.P., Faller, B., Briat, C., Jacquelinet, C., Brami, M., Aoustin, M., et al.: Cost of dialysis in France. Nephrol Ther 3(3), 96–106 (2007)CrossRefPubMed
16.
Olsen, J., Bonnevie, B., Palmhoj-Nielsen, C., Povlsen, J.V.: Economic consequences of an increased number of patients on outgoing dialysis. Scand. J. Urol. Nephrol. 44(6), 452–458 (2010)CrossRefPubMed
17.
Hallinen, T., Soini, E.J., Martikainen, J.A., Ikaheimo, R., Ryynanen, O.P.: Costs and quality of life effects of the first year of renal replacement therapy in one Finnish treatment centre. J Med Econ 12(2), 136–140 (2009)CrossRefPubMed
18.
Malmstrom, R.K., Roine, R.P., Heikkila, A., Rasanen, P., Sintonen, H., Muroma-Karttunen, R., et al.: Cost analysis and health-related quality of life of home and self-care satellite haemodialysis. Nephrol. Dial. Transplant. 23(6), 1990–1996 (2008)CrossRefPubMed
19.
McFarlane, P.A., Pierratos, A., Redelmeier, D.A.: Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney Int. 62(6), 2216–2222 (2002)CrossRefPubMed
20.
Shih, Y.C., Guo, A., Just, P.M., Mujais, S.: Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients. Kidney Int. 68(1), 319–329 (2005)CrossRefPubMed
21.
Tediosi, F., Bertolini, G., Parazzini, F., Mecca, G., Garattini, L.: Cost analysis of dialysis modalities in Italy. Health Serv. Manage. Res. 14(1), 9–17 (2001)CrossRefPubMed
22.
Chui, B.K., Manns, B., Pannu, N., Dong, J., Wiebe, N., Jindal, K., et al.: Health care costs of peritoneal dialysis technique failure and dialysis modality switching. Am. J. Kidney Dis. 61(1), 104–111 (2013)CrossRefPubMed
23.
Villa, G., Fernandez-Ortiz, L., Cuervo, J., Rebollo, P., Selgas, R., Gonzalez, T., et al.: Cost-effectiveness analysis of the Spanish renal replacement therapy program. Perit. Dial. Int. 32(2), 192–199 (2012)CrossRefPubMedPubMedCentral
24.
Blotiere, P.O., Tuppin, P., Weill, A., Ricordeau, P., Allemand, H.: The cost of dialysis and kidney transplantation in France in 2007, impact of an increase of peritoneal dialysis and transplantation. Nephrol Ther 6(4), 240–247 (2010)CrossRefPubMed
25.
Salonen, T., Reina, T., Oksa, H., Sintonen, H., Pasternack, A.: Cost analysis of renal replacement therapies in Finland. Am. J. Kidney Dis. 42(6), 1228–1238 (2003)CrossRefPubMed
26.
Lamas Barreiro, J.M., Alonso, S.M., Saavedra Alonso, J.A., Gandara, M.A.: Costs and added value of haemodialysis and peritoneal dialysis outsourcing agreements. Nefrologia 31(6), 656–663 (2011)PubMed
27.
Cleemput, I., Beguin, C.L., De la Kethulle, Y., Gerkens, S., Jadoul, M., Verpooten, G., et al.: Organisation et financement de la dialyse chronique en Belgique. KCE reports 124B. Bruxelles: Centre fédéral d’expertise des soins de santé (2010)
28.
Agar, J.W., Hawley, C.M., George, C.R., Mathew, T.H., McDonald, S.P., Kerr, P.G.: Home haemodialysis in Australia—is the wheel turning full circle? Med. J. Aust. 192(7), 403–406 (2010)PubMed
29.
McFarlane, P.A.: Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada. Semin. Dial. 17(2), 118–124 (2004)CrossRefPubMed
30.
Soroka, S.D., Kiberd, B.A., Jacobs, P.: The marginal cost of satellite versus in-center hemodialysis. Hemodial. Int. 9(2), 196–201 (2005)CrossRefPubMed
31.
32.
Komenda, P., Gavaghan, M.B., Garfield, S.S., Poret, A.W., Sood, M.M.: An economic assessment model for in-center, conventional home, and more frequent home hemodialysis. Kidney Int. 81(3), 307–313 (2012)CrossRefPubMed
33.
Icks, A., Haastert, B., Gandjour, A., Chernyak, N., Rathmann, W., Giani, G., et al.: Costs of dialysis—a regional population-based analysis. Nephrol. Dial. Transplant. 25(5), 1647–1652 (2010)CrossRefPubMed
34.
Piwko, C., Vicente, C., Marra, L., Jivraj, F., Appel, E., Wolpin, J., et al.: The STARRT trial: a cost comparison of optimal vs sub-optimal initiation of dialysis in Canada. J. Med. Econ. 15(1), 96–104 (2012)CrossRefPubMed
35.
Barnieh, L., Manns, B.J., Klarenbach, S., McLaughlin, K., Yilmaz, S., Hemmelgarn, B.R.: A description of the costs of living and standard criteria deceased donor kidney transplantation. Am. J. Transplant. 11(3), 478–488 (2011)CrossRefPubMed
36.
Tuppin, P., de, R.L., Weill, A., Ricordeau, P., Merliere, Y.: French national health insurance information system and the permanent beneficiaries sample. Rev. Epidemiol. Sante Publique 58(4), 286–290 (2010)CrossRefPubMed
37.
Jacquelinet, C., Lange, C., Briancon, S.: ESRD prevalence in 2011. REIN annual report 2011. Nephrol. Ther. 9, S39–S64 (2013)
38.
Sainsaulieu, Y., Sambuc, C., Logerot, H., Bongiovanni, I., Couchoud, C.: Cost of a renal graft: medico-economic analysis of the amount reimbursed by the National health insurance to finance the preliminary and peripheral step of renal transplantation. Nephrol. Ther. 10(4), 228–235 (2014)CrossRefPubMed
39.
Couchoud, C., Dantony. E., Elsensohn. M.H., Villar, E., Ecochard, R.: Modelling treatment trajectories to optimize the organization of renal replacement therapy and public health decision-making. Nephrol. Dial. Transplant. 28(9), 2372–2382 (2013)CrossRefPubMed
40.
Couchoud, C., Couillerot, A.L., Dantony, E., Elsensohn, M.H., Labeeuw, M., Villar, E., et al.: Economic impact of a modification of the treatment trajectories of patients with end-stage renal disease. Nephrol. Dial. Transplant. 30(12): 2054–2068 (2015)CrossRefPubMedPubMedCentral
41.
Just, P.M., Riella, M.C., Tschosik, E.A., Noe, L.L., Bhattacharyya, S.K., de, C.F.: Economic evaluations of dialysis treatment modalities. Health Policy 86(2–3), 163–180 (2008)CrossRefPubMed
42.
Peeters, P., Rublee, D., Just, P.M., Joseph, A.: Analysis and interpretation of cost data in dialysis: review of Western European literature. Health Policy 54(3), 209–227 (2000)CrossRefPubMed
43.
Polder, J.J., Barendregt, J.J., van, O.H.: Health care costs in the last year of life—the Dutch experience. Soc. Sci. Med. 63(7), 1720–1731 (2006)CrossRefPubMed
44.
Stroupe, K.T., Fischer, M.J., Kaufman, J.S., O’Hare, A.M., Sohn, M.W., Browning, M.M., et al.: Predialysis nephrology care and costs in elderly patients initiating dialysis. Med. Care 49(3), 248–256 (2011)CrossRefPubMed
45.
Lee, C.P., Chertow, G.M., Zenios, S.A.: A simulation model to estimate the cost and effectiveness of alternative dialysis initiation strategies. Med. Decis. Mak. 26(5), 535–549 (2006)CrossRef
Metadaten
Titel
A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events
verfasst von
Anne-Line Couillerot-Peyrondet
Cléa Sambuc
Yoël Sainsaulieu
Cécile Couchoud
Isabelle Bongiovanni-Delarozière
Publikationsdatum
05.05.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
The European Journal of Health Economics / Ausgabe 4/2017
Print ISSN: 1618-7598
Elektronische ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-016-0801-6

Weitere Artikel der Ausgabe 4/2017

The European Journal of Health Economics 4/2017 Zur Ausgabe

Original Paper

What happens to drinking when alcohol policy changes? A review of five natural experiments for alcohol taxes, prices, and availability

Editorial

A perspective on the health care expenditures for defensive medicine

Original Paper

Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis

Original Paper

Estimation of a physician practice cost function

Original Paper

Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece

Original Paper

Out-of-pocket expenditures for pharmaceuticals: lessons from the Austrian household budget survey